BRAF and skin cancer: This paradoxical stimulation is believed to be mediated by the BRAFi-induced dimerization of mutated BRAF and wild-type (WT) RAF isoforms, which enhances cellular responses such as cell proliferation, survival and growth, subsequently driving the progression of skin cancers [11].